Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Matrix metalloproteinases (MMPs) are enzymes known for degrading the extracellular matrix (ECM).
• MMPs are upregulated in most tumor types and play roles in tumor invasion and metastasis.
• Recent research shows MMPs also influence early tumor cell growth and intracellular processes.

Purpose of the Study:

• To provide an overview of recent findings on MMP action in tumors.
• To elucidate the mechanisms by which MMPs induce phenotypic and genotypic alterations facilitating tumor progression.
• To highlight novel therapeutic targets by understanding MMP-induced epithelial-mesenchymal transition (EMT).

Main Methods:

• Review of recent scientific literature on MMPs in cancer.
• Analysis of studies investigating MMPs' roles in extracellular matrix degradation and cellular signaling.
• Examination of research on MMPs' impact on epithelial-mesenchymal transition (EMT) and genomic instability.

Main Results:

• MMPs are implicated in both early-stage tumor growth and later-stage invasion and metastasis.
• MMPs can cleave intracellular targets, leading to mitotic abnormalities and genomic instability.
• Tumor-associated MMPs stimulate processes like EMT, crucial for cancer cell invasion.

Conclusions:

• MMPs are key drivers of tumor progression through diverse mechanisms.
• Targeting specific MMP pathways, particularly those inducing EMT, offers potential for novel cancer therapies.
• Further research into MMP targets and signaling pathways is essential for effective therapeutic development.